REMD-477 (Volagidemab) for Type 1 Diabetes Mellitus: Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032 - Focus on 7 Major Markets
24 janv. 2024 09h11 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "REMD-477 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
ITI-1000 (pp65 DC vaccine) for Glioblastoma Multiforme (GBM): Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032 - Focus on US, Germany, France, Italy, Spain, UK, and Japan
24 janv. 2024 09h09 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "ITI-1000 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
EO 2401 for GBM: A Donor-Derived, Off-the-Shelf, Microbiome Therapeutic Cancer Peptide Vaccine - Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032
24 janv. 2024 09h06 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "EO 2401 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
APT-1011 for EoE Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032 - Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
24 janv. 2024 09h05 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "APT-1011 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "APT-1011 Emerging Drug...
LAM561 (2-OHOA: 2-hydroxyoleic acid) for GBM: Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032 - Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
24 janv. 2024 09h03 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "LAM561 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
SM04690 for Osteoarthritis: Emerging Drug Insight and Market Forecasts to 2032 - Focus on 6 Major Markets
24 janv. 2024 08h59 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "SM04690 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "SM04690 Emerging Drug...
DCVax-L in Glioblastoma Multiforme Market Forecasts to 2032
24 janv. 2024 08h58 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "DCVax-L Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The global healthcare...
SVT-15473 Emerging Drug Analysis and Market Forecasts, 2019-2023 and 2023-2029: A New and Innovative Ocular Nano-Emulsion of Super-Potent Steroid Clobetasol Propionate
24 janv. 2024 08h14 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "SVT-15473 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Global Market Insights...
DEXCYU Emerging Drug Insight and Market Forecasts, 2019-2023 and 2023-2032: A Dexamethasone Intra-ocular Suspension Marketed for Treating Postoperative Inflammation
24 janv. 2024 08h13 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "DEXCYU Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
K-321 (Ripasudil) for Fuchs Endothelial Corneal Dystrophy (FECD): Emerging Drug Insights and Market Forecasts, 2019-2023 and 2023-2032
24 janv. 2024 08h12 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "K-321 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...